Pfizer Executive admits COVID vaccine never tested on preventing transmissions
During a hearing on the European Union’s COVID-19 response, Pfizer’s president of international developed markets, Janine Small, admitted that its vaccine had never been tested before its release to the general public on its ability to prevent the transmission of COVID when asked by Dutch politician and a current Member of the European Parliament (MEP) Robert “Rob” Roos.
“Regarding the question around did we know about stopping immunization before it entered the market…No.,” Small replied with a smirk when asked by Roos if the Pfizer’ COVID vaccine was ever tested to stop the transmission of the virus before it entered the market.
During the coronavirus epidemic, Pfizer, which developed an mRNA vaccine for the covid-19 virus together with the Biontech company, has made more than $ 45 billion in turnover since 2021, thanks to the covid vaccines alone. At least 10 billion dollars of this turnover was recorded as profit.
Pharmaceutical companies sessions were held in the European Parliament in Brussels. CEOs and officials of many pharmaceutical companies operating in Europe attended the hearings and were questioned by MEPs.
Pfizer CEO Albert Bourla did not attend the session. Pfizer was represented by Janine Small, the company's official and manager.
Dutch Member of the European Parliament Rob Roos questioned the Pfizer official: “Was Pfizer's covid vaccine tested before it was released, whether it could prevent the spread of the disease? If tested, is it possible to share the data with our commission? And I demand a very clear answer: yes or no. Thank you."
The Pfizer official admitted that the tests were not carried out: “Did we know if the vaccines prevented transmission before they were released? No, haha. This is, you know, we had to move at the speed of science and learn how the market works.”
The two most widely used covid vaccines in the world are vaccines produced by AstraZeneca and Pfizer-Biontech.
Both companies said they "significantly reduce the transmission of coronavirus and the spread of disease" when vaccines become available in 2021.